Latest

IRC (01029.HK): Two-for-One Rights Issue to Raise Up to HK$301.9m, Backed by Controlling Shareholder ] On 27 Oct 2026, IRC (01029.HK) proposed a two-for-one rights issue at HK$0.315 to raise up to HK$301.9m, underwritten by its 73.95% shareholder in a connected transaction.
08:20
NewTimeSpaceIRC01029.HK
MEITUAN-W (03690.HK): Issues RMB8bn Senior Notes at 2.50% and 3.10% ] On 28 Oct 2026, MEITUAN-W (03690.HK) priced RMB4.5bn 2.50% 2031 notes and RMB3.5bn 3.10% 2036 notes at par, raising RMB8bn mainly to refinance offshore debt.
08:08
NewTimeSpaceMEITUAN-W03690.HK
SANDS CHINA (01928.HK): US$1bn Notes Priced at 6.400% for 2032 and 6.700% for 2033 ] On 28 Oct 2026, SANDS CHINA (01928.HK) priced US$700m 6.400% 2032 notes and US$300m 6.700% 2033 notes, raising about US$989m net to redeem its 2027 notes.
07:39
NewTimeSpaceSANDS CHINA01928.HK
NEXCHIP (02249.HK): Chairman Proposes A- and H-Share Buy-backs of Up to RMB800m and HK$600m ] On 27 Oct 2026, NEXCHIP (02249.HK) said chairman Cai Guozhi proposed buying back RMB500-800m of A shares and HK$300-600m of H shares, subject to approvals.
07:34
NewTimeSpaceNexchip02249.HK
ASMPT (00522.HK): Q3 Bookings Hit Record; Revenue Up 48.7% to HK$5.25bn ] On 27 Oct 2026, ASMPT (00522.HK) posted record Q3 bookings of HK$8.45bn, up 137.9% YoY, and revenue of HK$5.25bn, up 48.7%, with Q4 guidance of US$670-730m.
07:30
NewTimeSpaceASMPT00522.HK
LUFAX (06623.HK): Q3 Revenue RMB6.18bn, Net Loss RMB1.49bn ] On 28 Oct 2026, LUFAX (06623.HK) posted Q3 revenue of RMB6.18bn, down 4.6%, and a net loss of RMB1.49bn, as credit impairment and tax charges rose.
07:26
NewTimeSpaceLUFAX06623.HK
51WORLD (06651.HK): Li Yi Extends Lock-up Commitment to End-2030 ] On 28 Oct 2026, 51WORLD (06651.HK) said chairman and CEO Li Yi extended the lock-up on his 19.70% H-share stake from December 2026 to 30 December 2030.
07:23
NewTimeSpace51WORLD06651.HK
BRAINAURORA-B (06681.HK): Depression Cognitive Assessment Software Wins Class II Device Registration ] On 27 Oct 2026, BRAINAURORA-B (06681.HK) won Class II device registration for cognitive assessment software for depression patients.
07:22
NewTimeSpaceBRAINAURORA-B06681.HK
C FIN INT INV (00721.HK): Proposes Issue and Buy-back Mandates; AGM on 27 November ] On 28 Oct 2026, C FIN INT INV (00721.HK) proposed 20% issue and 10% buy-back mandates for its 27 Nov AGM, plus director re-election and auditor re-appointment.
07:12
NewTimeSpaceC FIN INT INV00721.HK
IMMUNOTECH-B (06978.HK): To Place Up to 123.5m New Shares, Raising at Least HK$36.1m ] On 28 Oct 2026, IMMUNOTECH-B (06978.HK) agreed to place up to 123.5m new shares at a minimum HK$0.300 each, a 13.04% discount, to raise at least HK$36.1m net.
07:11
NewTimeSpaceIMMUNOTECH-B06978.HK
FS.COM (03355.HK): trustee buys 370,000 H shares under share award scheme at average HK$37.491 ] FS.COM (03355.HK) said the trustee bought 370,000 H shares under its H-share award scheme at an average of HK$37.491, for a total of about HK$13.87 million.
22:17
FS.COM03355.HKShare Award Scheme
OCUMENSION-B (01477.HK): fluocinolone acetonide intravitreal implant cleared by NMPA for mainland China production ] OCUMENSION-B (01477.HK) said the NMPA approved mainland China production of its fluocinolone acetonide intravitreal implant, adding a domestic supply source.
22:15
OCUMENSION-B01477.HKDrug Approval
IDREAMSKY (01119.HK): HK$386 million convertible bond conversion price cut from HK$3.58 to HK$3.51, effective 27 October ] IDREAMSKY (01119.HK) cut the conversion price of its HK$386 million 5.00% convertible bonds due 2028 from HK$3.58 to HK$3.51, effective 27 October 2026.
21:32
IDREAMSKY01119.HKconvertible bonds
ZHONG JI LS (00767.HK): fourth supplemental agreement on 25% Asia Integrated Cell Bank deal moves debt repayment to nine months after completion ] ZHONG JI LS (00767.HK) signed a fourth supplemental agreement on its 25% Asia Integrated Cell Bank deal, moving debt repayment to nine months after completion.
21:29
ZHONG JI LS00767.HKmajor transaction
IDREAMSKY (01119.HK): placing of 187,856,000 shares at HK$0.31 completed, net proceeds about HK$56.63 million for AI agents and games ] IDREAMSKY (01119.HK) placed 187,856,000 new shares at HK$0.31, raising net proceeds of about HK$56.63 million for AI agent development and game operations.
21:27
IDREAMSKY01119.HKPlacing
SCHOLAR EDU (01769.HK): trustee buys 297,000 shares under share award scheme at average HK$0.71, holding rises to 7.93% ] SCHOLAR EDU (01769.HK) said the trustee bought 297,000 shares under the award scheme at an average HK$0.71, lifting its holding to 53,440,000, or 7.93%.
21:17
SCHOLAR EDU01769.HKShare Award Scheme
CICC (03908.HK): share-swap absorption merger of Dongxing Securities and Cinda Securities closed on 26 October, all assets, liabilities and outstanding bonds assumed ] CICC (03908.HK) closed on 26 October 2026 its share-swap merger of Dongxing Securities and Cinda Securities, taking over their assets and outstanding bonds.
21:11
CICC03908.HKNewTimeSpace
QINGCI GAMES (06633.HK): RMB50 million connected loans to chairman Yang Xu and CEO Huang Zhiqiang at 3.2% for one year ] QINGCI GAMES (06633.HK) lent chairman Yang Xu and CEO Huang Zhiqiang up to RMB46 million and RMB4 million at 3.2% for personal financial arrangements.
20:00
QINGCI GAMES06633.HKFinancial Assistance
ESTUN (02715.HK): RMB210.6 million acquisition of 19.4574% stake in Estun Jiangsu Intelligent lifts holding to 69.608% ] ESTUN (02715.HK) will buy a 19.4574% stake in Estun Jiangsu Intelligent for RMB210.6 million, raising its holding to 69.608%; the target remains a subsidiary.
19:54
ESTUN02715.HKacquisition
CSPC PHARMA (01093.HK): SYS6043 Phase I/II results in advanced breast cancer out, TNBC ORR at 75.0% ] CSPC PHARMA (01093.HK) reported SYS6043 Phase I/II data at ESMO 2026, with ORR of 75.0% in TNBC, 69.6% in HER2+ and 53.7% in HR+/HER2- breast cancer.
19:33
CSPC PHARMA01093.HKESMO
Previous1..89 101112..606     606 pages total
×
Share to WeChat

Open WeChat, use "Scan," and share to my Moments